Affinity for the insulin-like growth factor-II (IGF-II) receptor inhibits autocrine IGF-II activity in MCF-7 breast cancer cells

Molecular Endocrinology

Volumn 10, Issue 3, 1996, Pages 286-297

  Ellis, Matthew J C ^a,b   Leav, Brett A ^a   Yang, Zejia ^a   Rasmussen, Audrey ^a   Pearce, Amelia ^a   Zweibel, James A ^a   Lippman, Marc E ^a   Cullen, Kevin J ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN B; SOMATOMEDIN C; SOMATOMEDIN RECEPTOR;

ARTICLE; AUTOCRINE EFFECT; BREAST CANCER; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR AFFINITY;

AMINO ACID SEQUENCE; BINDING SITES; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL DIVISION; CULTURE MEDIA, SERUM-FREE; EXTRACELLULAR SPACE; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; NEOPLASMS, HORMONE-DEPENDENT; PROTEIN BINDING; RECEPTOR, IGF TYPE 1; RECEPTOR, IGF TYPE 2; RECOMBINANT FUSION PROTEINS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSFECTION;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0029885645     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.10.3.286     Document Type: Article

References (64)

1. Kornfield S 1992 Structure and function of the mannose 6-phosphate/insulin-like growth factor II receptors. Annu Rev Biochem 61:307-330
2. Gansler T, Furlanetto R, Gramling TS, Robinson KA, Blocker N, Buse M, Sens DA, Garvin AJ 1986 Antibody to Type I insulin-like growth factor receptor inhibits the growth of Wilm's tumor in culture and in athymic nude mice. Am J Pathol 135:961-966
3. El-Badry O, Minniti C, Kohn E, Houghton P, Daughaday W, Helman L 1990 Insulin-like growth factor II acts as an autocrine growth and motility factor in human rhabdomyosarcoma tumors. Cell Growth Differen 1:325-330
4. Neilsen FC, Wang E, Gammeltoft S 1991 Receptor binding, endocytosis and mitogenesis of insulin-like growth factors I and II in fetal rat brain neurons. J Neurochem 56:12-21
5. Baserga R 1992 IGF-I receptor as the restriction point of the cell cycle. Ann NY Acad Sci 663:154-157
6. Baserga R 1994 Oncogenes and the Strategy of Growth Factors. Cell 79:927-930
7. Baserga R 1995 The insulin-like growth factor I receptor: a key to tumor growth? Cancer Res 55:249-252
8. Harrington E, Bennett M, Fanidi A, Evan G 1994 c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J 13:3286-3295
9. Nishimoto I, Hata Y, Otaga E, Kojima I 1987 Insulin-like growth factor II stimulates calcium flux in competent BALB/c 3T3 cells primed with epidermal growth factor. Characteristics of calcium influx and involvement of GTP-binding protein. J Biol Chem 262:12120-12126
10. Minniti C, Kohn E, Grubb J, Sly W, Oh Y, Muller H, Rosenfeld R, Helman L 1992 The insulin-like growth factor II (IGF-II)/mannose-6-phosphate receptor mediates IGF-II-induced motility in human rhabdomyosarcoma cells. J Biol Chem 267:9000-9004
11. Nishimoto I, Murayama Y, Katada T, Ui M, Ogata E 1989 Possible direct linkage of insulin-like growth factor receptor with guanine nucleotide-binding proteins. J Biol Chem 264:14029
12. Murayama Y, Okamoto T, Ogata E, Asano T, Iiri T, Katata T, Ui M, Grubb JH, Sly WS, Nishimoto I 1990 Distinctive regulation of the functional linkage between the human cation-independent mannose 6-phosphate receptor and GTP-binding proteins by insulin-like growth factor II and mannose 6-phosphate. J Biol Chem 265:17456-17462
13. Okamoto T, Katata T, Murayama Y, Ui M, Ogata E, Nishimoto I 1990 A simple structure encodes G protein-activating function of the IGF-II/mannose 6-phosphate receptor. Cell 62:709-717
14. Korner C, Nurnberg B, Uhde M, Braulke T 1995 Mannose 6-phosphate/Insulin-like growth factor II receptor fails to interact with G-proteins. J Biol Chem 270:287-295
15. Neilsen FC, Haselbacher G, Christiansen J, Lake M, Gronborg M, Gammeltoft S 1993 Biosynthesis of 10 kDa and 7.5 kDa insulin-like growth factor II in a human Rhabdomyosarcoma cell line. Mol Cell Endocrinol 93: 87-95
16. Lau MMH, Stewart CEH, Liu Z, Bhatt H, Rotwein P, Stewart CL 1994 Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality. Genes Dev 8:2953-2963
17. Wang Z-Q, Fung MR, Barlow DP, Wagner EF 1994 Regulation of embryonic growth and lysosomal targeting by the imprinted Igf2/Mpr gene. Nature 372:464-467
18. De Souza AT, Hankins GR, Washington MK, Fine RL, Orton TC, Jirtle RL1995 Frequent Loss of heterozygosity on 6q at the mannose 6-phosphate/insulin-like growth factor II receptor locus in human hepatocellular tumors. Oncogene 10:1725-1729
19. Devilee P, van Vliet M, van Sloun P, Kuipers Dijkshoorn N, Hermans J, Pearson PL, Cornelisse CJ 1991 Allelo-type of human breast carcinoma: a second major site for loss of heterozygosity is on chromosome 6q. Oncogene 6:1705-1711
20. Millikin D, Meese E, Vogelstein B, Witkowski C, Trent J 1991 Loss of heterozygosity for loci on the long arm of chromosome 6 in human malignant melanoma. Cancer Res 51:5817-5820
21. Foulkes WD, Ragoussis J, Stamp GW, Allan GJ, Trowsdale J 1993 Frequent loss of heterozygosity on chromosome 6 in human ovarian carcinoma. Br J Cancer 67: 551-559
22. Neilsen FC, Ostergaard L, Nielson J, Christiansen J 1995 Growth-dependent translation of IGF-II mRNA by a rapamycin-sensitive pathway. Nature 377:358-362
23. Yee D, Cullen KJ, Paik S, Perdue JF, Hampton B, Schwartz A, Lippman ME, Rosen N 1988 Insulin-like growth factor II mRNA expression in human breast cancer. Cancer Res 48:6691-6696
24. Yee D, Paik S, Lebovic GS, Marcus RR, Favoni RE, Cullen KJ, Lippman ME, Rosen N 1989 Analysis of insulin-like growth factor I gene expression in malignancy: evidence for a paracrine role in human breast cancer. Mol Endocrinol 3:509
25. Osborne CK, Coronado EB, Kitten LJ, Arteaga CI, Fuqua SA, Ramasharma K, Marshall M, Li CH 1989 Insulin-like growth factor II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor. Mol Endocrinol 3:1701-1709
26. Stewart AJ, Johnson MD, May FEB, Westley BR 1990 Role of insulin-like growth factors and type I insulin-like growth factor receptor in the estrogen stimulated proliferation of human breast cancer cells. J Biol Chem 265: 31172-21178
27. Cullen KJ, Yee D, Sly WS, Perdue J, Hampton B, Lippman ME, Rosen N 1990 Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Res 50:48-53
28. Cullen KJ, Lippman ME, Chow D, Hill S, Rosen N, Zwiebel JA 1992 Insulin-like growth factor-II overexpression in MCF-7 cells induces phenotypic changes associated with malignant progression. Mol Endocrinol 6: 91-100
29. Daly RJ, Harris WH, Wang DY, Darbre PD 1991 Autocrine production of insulin-like growth factor II using an inducible expression system results in reduced estrogen sensitivity of MCF-7 human breast cancer cells. Cell Growth Differen 2:457-464
30. Cullen KJ, Smith HS, Hill S, Rosen N, Lippman ME 1991 Growth factor messenger RNA expression by human breast fibroblasts from benign and malignant lesions. Cancer Res 51:4978
31. Singer C, Rassmussen A, Smith H, Lippman M, Lynch H, Cullen K 1995 Malignant breast epithelium selects for IGF-II expression in breast stroma. Evidence for paracrine function. Cancer Res 55:2448-2454
32. Papa V, Biancamaria G, Clark GM, McGuire WL, Moore D, Fujita-Yamaguchi Y, Riccardo V, Goldfine ID, Pezzino V 1993 Insulin-like growth factor receptors are overexpressed and predict a low risk in human breast cancer. Cancer Res 53:3736-3740
33. Zhoa Y, Escot C, Maudelonde T, Puech C, Rouanet P, Rochefort H 1993 Correlation between Mannose-6-phosphate/IGF-II receptor and Cathepsin D RNA levels by in situ hybridization in benign and malignant mammary tumors. Cancer Res 53:2901-2905
34. Sakano K, Enjoh T, Numata F, Fujiwara H, Marumoto Y, Higashihash N, Sata Y, Perdue J, Fujita-Yamaguchi Y 1991 The design, expression, and characterisation of human insulin-like growth factor-II (IGF-II) mutants specific for either the IGF-II/cation-independent mannose-6-phosphate receptor or IGF-I receptor. J Biol Chem 266:20626-20635
35. Burgisser D, Roth B, Giger R, Luthi C, Weigl S, Zarn J, Humbel R 1991 Mutants of human insulin-like growth factor II with altered affinities for the type I and type 2 Insulin-like growth factor receptors. J Biol Chem 266: 1029-1033
36. Beukers MW, Youngman O, Zhang H, Ling N, Rosenfeld R 1991 [Leu 27] Insulin-like growth factor II is highly selective for the type-II IGF receptor in binding, cross-linking and thymidine incorporation experiments. Endocrinology 128:1201-1203
37. Miller DA, Rosman GJ 1989 Improved retroviral vectors for gene transfer and expression. Biotechniques 7: 980-990
38. Cascieri MA, Chicchi GG, Applebaum J, Hayes NS, Green BG, Bayne ML 1988 Mutants of insulin-like growth factors I with reduced affinity for the insulin-like growth factor receptor. Biochemistry 27:3229-3233
39. Bach A, Hsieh S, Sakono K, Fujiwara H, Perdue J, Rechler M 1993 Binding of mutants of human insulin-like growth factor-II to insulin-like growth factor binding proteins 1 to 6. J Biol Chem 268:9246-9254
40. Johnson MD, Torri JA, Lippman ME, Dickson RB 1993 The role of cathepsin D in the invasiveness of human breast cancer cells. Cancer Res 53:873-877
41. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S, Gotoh Y, Nishida E, Kawashima H, Metzger D, Cambon P 1995 Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270:1491-1494
42. Kato H, Faaria T, Stannard B, Roberts Jr C, LeRoith D 1993 Role of tyrosine kinase activity in signal transduction by the insulin-like growth factor I (IGF-I) receptor. J Biol Chem 268:2655-2661
43. White MF, Kahn CR 1994 The insulin signaling system. J Biol Chem. 269:1-4
44. Hudkins W, Hampton B, Burgess W, Perdue J 1992 The identification of O-glycosylated precursors of insulin-like growth factor II. J Biol Chem 267:8153-8160
45. Claussen M, Buergisser D, Schuller AGP, Matzner U, Braulke T 1995 Regulation of insulin-like growth factor (IGF)-binding protein - 6 and mannose 6-phosphate/IGF-II receptor expression in IGF-II-overexpressing NIH 3T3 cells. Mol Endocrinol 9:902-912
46. Gaidano G, Hauptschein RS, Parsa NZ, Offit K, Rao PH, Lenoir G, Knowles DM, Chaganti RS, Dalla-Favera R 1992 Deletions involving two distinct regions of 6q in B-cell non-Hodgkin lymphoma. Blood 80:1781-1787
47. Morita R, Saito S, Ishikawa J, Ogawa O, Yoshida O, Yamakawa K, Nakamura Y 1991 Common regions of deletion on chromosomes 5q, 6q, and 10q in renal cell carcinoma. Cancer Res 51:5817-5820
48. De Sousa AT, Hankins GR, Washington MK, Orton TC, Jirtle RL 1995 M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nat Genet 11:447-449
49. Rogler CE, Yang D, Rossetti L, Donohoe J, Alt E, Chang CJ, Rosenfeld R, KN, Hintz R 1994 Altered body composition and increased frequency of diverse malignancies in insulin-like growth factor-II transgenic mice. J Biol Chem 269:13779-13784
50. Dennis P, Rifkin D 1991 Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor-II receptor. Proc Natl Acad Sci USA 88: 580-584
51. Haig D, Graham C 1991 Genomic imprinting and the strange case of the insulin-like growth factor II receptor. Cell 64:1045-1046
52. Kalscheuer VM, Mariman EC, Schepens MT, Rehder H, Ropers HH 1993 The insulin-like growth factor type-2 receptor is imprinted in the mouse but not in humans. Nat Genet 5:74-78
53. Ogawa O, Eccles MR, Szeto J, McNoe LA, Yun K, Maw MA, Smith PJ, Reeve AE 1993 Relaxation of insulin-like growth factor II gene in imprinting implicated in Wilm's tumor. Nature 362:749-751
54. Xu Y, Goodyer CG, Deal C, Polychronakos C 1993 Functional polymorphism in the parental imprinting of the human IGF2R gene. Biochem Biophys Res Commun 197:747-754
55. Knudson A 1986 Genetics of human cancer. Annu Rev Genet 20:231-251
56. Nissley SP, Rechler MM 1986 Insulin-like growth factors: biosynthesis, receptors, and carrier proteins. Horm Proteins Pept 12:127-203
57. Unterman T, Simmons R, Glick R, Ogata E 1993 Circulating levels of insulin, insulin-like growth factor-I (IGF-I), IGF-II, and IGF-binding proteins in the small for gestational age fetal rat. Endocrinology 132:327-336
58. Markowitz D, Goff S, Bank A 1988 A safe packaging line for gene transfer: separating viral genes on two different plasmids. J Virol 62:1120-1124
59. Miller AD, Buttimore C 1986 Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol Cell Biol 6:2895-2902
60. Enoch T, Zinn K, Maniatis T 1986 Activation of the human beta-interferon gene requires an interferon-inducible factor. Mol Cell Biol 6:801-810
61. Zinn K, DiMaio D, Maniatis T 1983 Identification of two distinct regulatory regions adjacent to the human beta-interferon gene. Cell 34:865-879
62. Frey RS, Hathaway MR, Dayton WR 1994 Comparison of the effectiveness of various procedures for reducing or eliminating insulin-like growth factor-binding protein interference with insulin-like growth factor-I radioimmunoassays on porcine sera. J Endocrinol 140:229-237
63. Porstmann B, Porstmann T, Nugel E 1981 Comparison of chromogens for the determination of horseradish peroxidase as a marker for enzyme assay. J Clin Chem Clin Biochem 19:435-439
64. Valenzano K, Remmler J, Lobel P 1995 Soluble insulin-like growth factor II/mannose 6-phosphate receptor carries multiple high molecular weight forms of insulin-like growth factor II in fetal bovine serum. J Biol Chem 270: 16441-16448